Literature DB >> 31969255

Prevalence of hypermutator isolates of Achromobacter spp. from cystic fibrosis patients.

Winnie Ridderberg1, Kurt Jensen Handberg2, Niels Nørskov-Lauritsen2.   

Abstract

Bacteria colonising the lungs of cystic fibrosis (CF) patients encounter high selective pressures. Hypermutation facilitates adaptation to fluctuating environments, and hypermutator strains are frequently isolated from CF patients. We investigated the prevalence of hypermutator isolates of Achromobacter spp. among patients affiliated with the CF Centre in Aarhus, Denmark. By exposure to rifampicin, the mutation frequency was determined for 90 isolates of Achromobacter spp. cultured from 42 CF patients; 20 infections were categorised as chronic, 22 as intermittent. The genetic mechanisms of hypermutation were examined by comparing DNA repair gene sequences from hypermutator and normomutator isolates. Achromobacter spp. cultured from 11 patients were categorised as hypermutators, and this phenotype was exclusively associated with chronic infections. Isolates of the Danish epidemic strain (DES) of Achromobacter ruhlandii cultured from patients from both Danish CF centres showed elevated mutation frequencies. The hypermutator state of Achromobacter spp. was most commonly associated with nonsynonymous mutations in the DNA mismatch repair gene mutS; a single clone had developed a substitution in the S-adenosyl-L-methionine-dependent methyltransferase putatively involved in DNA repair mechanisms, but not previously linked to the hypermutator phenotype. Hypermutation is prevalent among clinical isolates of Achromobacter spp. and could be a key determinant for the extraordinary adaptation and persistence of DES.
Copyright © 2020 The Authors. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Keywords:  Achromobacterspp.; Chronic infection; Cystic fibrosis; Hypermutation

Year:  2020        PMID: 31969255     DOI: 10.1016/j.ijmm.2020.151393

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  6 in total

Review 1.  Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients' Lung.

Authors:  Quentin Menetrey; Pauline Sorlin; Estelle Jumas-Bilak; Raphaël Chiron; Chloé Dupont; Hélène Marchandin
Journal:  Genes (Basel)       Date:  2021-04-21       Impact factor: 4.096

2.  Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis.

Authors:  Migle Gabrielaite; Jennifer A Bartell; Niels Nørskov-Lauritsen; Tacjana Pressler; Finn C Nielsen; Helle K Johansen; Rasmus L Marvig
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

Review 3.  Mutators Enhance Adaptive Micro-Evolution in Pathogenic Microbes.

Authors:  Kylie J Boyce
Journal:  Microorganisms       Date:  2022-02-15

4.  Induction of Broad β-lactam Resistance in Achromobacter ruhlandii by Exposure to Ticarcillin Is Primarily Linked to Substitutions in Murein Peptide Ligase Mpl.

Authors:  Camilla Andersen; Migle Gabrielaite; Niels Nørskov-Lauritsen
Journal:  Microorganisms       Date:  2022-02-11

5.  Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients.

Authors:  Laura Veschetti; Angela Sandri; Cristina Patuzzo; Paola Melotti; Giovanni Malerba; Maria M Lleo
Journal:  Microb Genom       Date:  2021-07

6.  Achromobacter spp. genetic adaptation in cystic fibrosis.

Authors:  Migle Gabrielaite; Finn C Nielsen; Helle K Johansen; Rasmus L Marvig
Journal:  Microb Genom       Date:  2021-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.